Mumbai, July 12 -- In a major crackdown under the "Safe Food, Safe Medicines, Safe Maharashtra" campaign, the Food and Drug Administration (FDA) of Maharashtra has seized stocks of Aciloc 150+ and Aciloc 300+ worth approximately Rs 2.45 crore and ordered a total market recall of the brand over deceptive labelling and branding concerns.

According to an official press note on Saturday, the action follows a routine inspection in Amravati, where it was observed that Cadila Pharmaceuticals Ltd., Ahmedabad, had long been licensed to manufacture and market Aciloc 150 and Aciloc 300, which contain Ranitidine as their Active Pharmaceutical Ingredient (API).

However, the company recently introduced Aciloc 150+ and Aciloc 300+, in which Ranitidine...